Your browser doesn't support javascript.
loading
Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.
Herring, Neil; Tapoulal, Nidi; Kalla, Manish; Ye, Xi; Borysova, Lyudmyla; Lee, Regent; Dall'Armellina, Erica; Stanley, Christopher; Ascione, Raimondo; Lu, Chieh-Ju; Banning, Adrian P; Choudhury, Robin P; Neubauer, Stefan; Dora, Kim; Kharbanda, Rajesh K; Channon, Keith M.
Afiliação
  • Herring N; Department of Physiology, Anatomy and Genetics, Burdon Sandersn Cardiac Science Centre, University of Oxford, Parks Road, Oxford OX13PT, UK.
  • Tapoulal N; Department of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, UK.
  • Kalla M; Department of Physiology, Anatomy and Genetics, Burdon Sandersn Cardiac Science Centre, University of Oxford, Parks Road, Oxford OX13PT, UK.
  • Ye X; Department of Physiology, Anatomy and Genetics, Burdon Sandersn Cardiac Science Centre, University of Oxford, Parks Road, Oxford OX13PT, UK.
  • Borysova L; Department of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, UK.
  • Lee R; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford UK.
  • Dall'Armellina E; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford UK.
  • Stanley C; Department of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, UK.
  • Ascione R; Department of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, UK.
  • Lu CJ; Oxford Acute Vascular Imaging Centre, Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford UK.
  • Banning AP; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford UK.
  • Choudhury RP; Bristol Heart Institute, Bristol Royal Infirmary, and Faculty of Health Sciences, University of Bristol, Horfield Road, Bristol UK.
  • Neubauer S; Department of Physiology, Anatomy and Genetics, Burdon Sandersn Cardiac Science Centre, University of Oxford, Parks Road, Oxford OX13PT, UK.
  • Dora K; Department of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, UK.
  • Kharbanda RK; National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way Oxford, UK.
  • Channon KM; Department of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford, UK.
Eur Heart J ; 40(24): 1920-1929, 2019 06 21.
Article em En | MEDLINE | ID: mdl-30859228

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropeptídeo Y / Vasos Coronários / Infarto do Miocárdio com Supradesnível do Segmento ST / Microcirculação Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropeptídeo Y / Vasos Coronários / Infarto do Miocárdio com Supradesnível do Segmento ST / Microcirculação Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article